Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dynamic Treatment Regimes for Personalized OUD Care
NCT07011758Phase 2Not yet recruiting
- Sponsor
- Brigham and Women's Hospital
- Start
- Jul 2028
- Primary completion
- Jun 2029
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial in opioid use disorder (OUD) (4 arms), sponsored by Brigham and Women's Hospital. Primary endpoints: Computerized Adaptive Test for Substance Use Disorder severity scores at 4 weeks, Retention in treatment at 4 weeks and 4 more. Planned start Jul 2028; status: not yet recruiting.
02
Conditions
opioid use disorder (OUD)
Beyond the preview
Go deeper on NCT07011758.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07011758.